ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 595

Radiographic Sacroiliitis Progression in an Early Axial Spondyloarthritis Cohort

Concepcion Castillo-Gallego1, Jesus Sanz2, Carmen Martin-Hervas3, Mireia Moreno4, Victoria Navarro-Compán5, Diana Peiteado1, Jorge Gratacos-Masmitja6, Eugenio De Miguel7 and Emilio Martín-Mola1, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Rheumatology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 3Radiology, Hospital Universitario La Paz, Madrid, Spain, 4Rheumatology, University Hospital Parc Taulí, Sabadell, Spain, 5Rheumatology, Rheumatologist, Madrid, Spain, 6Parc Tauli, S/N, Hospital Parc Tauli, Sabadell, Spain, 7Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), MRI, radiography and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: The current concept of axial Spondyloarhtritis (axSpA) considers non-radiographic axSpA (nr-axSpA) and Ankylosing Spondylitis (AS) as two stages of one disease. There are limited data available regarding rate of radiographic progression of the sacroiliac joints (SIJ) and the rate of transition from nr-axSpA to AS. The aim of the current study was to investigate radiographic progression in the SIJ in an early axSpA cohort.

Methods: Patients included in the study came from an early SpA cohort, from three centers of the ESPERANZA programme, a Spanish nationwide health management programme designed to provide excellence in care for early SpA. One of the inclusion criteria was symptom duration between 3 and 24 months. Every patient had a complete examination at baseline that included ESR, CRP, ASDAS-CRP, ASDAS-ESR, BASDAI, HLA-B27, pelvis x-Rays and Magnetic resonance (MRI) of SIJ. Pelvis x-Rays at baseline and at follow up were performed for every patient. These x-Rays were centrally digitized, anonymised and the SIJ were scored independently by two trained readers, according to the grading system of the modified New York criteria (mNYc). The readers scored images of both time points randomly and were blinded for all clinical data. MRI of SIJ were assessed independently and blinded by two trained readers,according to ASAS definition for bone marrow oedema (BME). Descriptive analysis was performed using SPSS program v.21.0. Cohen´s kappa coefficients were also calculated to assess agreement between the two readers (mNYc for x-Rays and ASAS definition for a positive MRI).

Results: Forty four patients (52% male) were included. Mean age was 34.4 years (range: 21-45) and 52.3% were HLA-B27 positive. Mean time since symptoms onset until baseline visit was 10.4 months (range: 3-24). Mean (SD) follow up period (between baseline x-Ray and last follow up x-Ray) was 3.6 (1.4) years (median 4 years). All patients fulfilled ASAS criteria for axSpA and 16 of them had AS according to mNYc at baseline, in the opinion of both readers. Interobserver agreement for the x-Ray reading at baseline visit (44 x-Rays) was at the limit between moderate and good (kappa 0.62), but it increased to very good agreement (kappa 0.90) at the x-Rays reading corresponding to the follow-up visit. Regarding MRI, data from 27 images were available for analysis and the kappa value for the ASAS definition of BME was 0.76 at baseline. Progression of sacroiliitis over follow up period by at least one grade at one side was found in 43.2% (19/44), in the opinion of both readers. Among the 28 nr-axSpA patients at baseline, 3 of them (11%) progressed to AS according to NYmc in the opinion of both readers. We also analyzed the possible association between all variables collected at baseline with radiographic progression but we did not find any statistically significant association for any of them.

Conclusion: Progression of radiographic sacroiliitis by at least one grade after a mean time of follow-up of 3.6 years occurs in almost half of the patients. The rate of progression from nrax-SpA to AS was 11%. The inter-reader reliability of pelvis x-Ray improves as disease progresses. Regarding to these results, pelvis x-Ray has a limited utility at early stages of axSpA.



Disclosure:

C. Castillo-Gallego,
None;

J. Sanz,
None;

C. Martin-Hervas,
None;

M. Moreno,
None;

V. Navarro-Compán,
None;

D. Peiteado,
None;

J. Gratacos-Masmitja,
None;

E. De Miguel,
None;

E. Martín-Mola,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-sacroiliitis-progression-in-an-early-axial-spondyloarthritis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology